• *About DRG**
Diabetes Reversal Group (DRG) is challenging one of healthcare’s most accepted assumptions that Type 2 diabetes must be managed for life with ongoing medication. Through the world’s only patented diabetes reversal system, DRG delivers a clinically validated telemedicine program designed to address the metabolic root cause of the disease, not just its symptoms.
The results are compelling: patients safely eliminate diabetic medications and achieve clinical reversal, defined as an A1C below 5.9.
• *Proven at Scale**
DRG is not an early-stage concept. It is a 16-year-old, profitable platform with:
• $35M+ in revenue tied to documented clinical outcomes
• 10,000+ patients with proven, patented reversal results
• A fully operational telemedicine infrastructure scaling internationally, with an India launch planned for early 2026
Our mission is bold and clear: reverse Type 2 diabetes for millions worldwide and help reduce the $966B global diabetes burden.
• *The Opportunity**
We are seeking a Diabetes Care Advisory Board Member to join DRG’s Advisory Board. someone with strong clinical judgment, credibility in diabetes care, and the vision to help shape what comes next. This role is ideal for a physician or clinical leader who understands both the limitations of the current standard of care and the opportunity to advance a better model.
• *Where You'll Have Impact**
Clinical Guidance & Oversight
• Provide expert input on DRG’s diabetes reversal protocols to help ensure they remain clinically sound, evidence-aligned, and scalable
• Advise on opportunities to strengthen care pathways, patient outcomes, and quality oversight
Patient Safety & Medication Deprescribing
• Help guide patient selection criteria, safety standards, and medication reduction pathways
• Support the development of deprescribing frameworks that are both responsible and practical across diverse patient populations
Clinical Validation & Credibility
• Support alignment of DRG’s outcomes with accepted clinical expectations and evidence standards
• Contribute to white papers, clinical materials, and peer-facing communications that strengthen DRG’s credibility
Growth & Clinical Scale
• Partner with DRG leadership as the platform expands into new markets and strategic opportunities
• Advise on how the clinical model can maintain integrity while scaling across populations, providers, and healthcare systems
• *Why This, Why Now**
Leaders in diabetes care see firsthand the burden of long-term disease management, the progression, the cost, and the limitations of medication dependent care. DRG offers a rare opportunity to help shape a model built around measurable outcomes, patient transformation, and scalable clinical delivery.
Type 2 diabetes reversal is no longer a theoretical conversation. What’s needed now is experienced clinical leadership to help bring it forward credibly, safely, and at scale.
Advisory
Board members will have a meaningful voice in that future.
• *Board Member Compensation
• Equity investment opportunity (IRA/401K eligible)
• Quarterly dividend distributions tied to equity ownership and company profitability
• *Our Commitment
DRG is committed to building a team and advisory community that reflects the diversity of the people we serve. We believe different perspectives strengthen our science, sharpen our thinking, and advance our mission. We welcome interest from clinicians and healthcare leaders of all backgrounds.
If you’ve dedicated your career to improving outcomes in Type 2 diabetes care and believe a better model is possible we’d like to talk.
Apply tot his job
Apply To this Job